Vivo Bio Tech Reports Nil Physical Share Re-lodgements August 2026

Reporting Entity and Period

The report enclosed with the filing was received from the company's Registrar and Share Transfer Agent (RTA), M/s. Aarthi Consultants Private Limited. The data covers the period ended August 2026.

Key Quantitative Figures

The status report for August 2026 contains the following data, all of which is reported as NIL:

• Number of requests received during the month: NIL
• Number of requests processed during the month: NIL
• Number of requests approved during the month: NIL
• Number of requests rejected during the month: NIL
• The average time taken for processing requests is noted as Not Applicable (NA).

Parties Involved

• Issuing Company: Vivo Bio Tech Limited (Scrip Code: 511509)
• Regulator: Securities and Exchange Board of India (SEBI)
• Stock Exchange: BSE Limited
• Registrar and Share Transfer Agent (RTA): Aarthi Consultants Private Limited

Signatories and Dates

• The covering letter to the BSE was signed by Bhavish Vijayvargiya, Company Secretary & Compliance Officer (Membership No. A77631) of Vivo Bio Tech Limited, and is dated September 10, 2026.
• The enclosed report from the RTA is dated September 7, 2026, and was signed by Jagan Mohan Gobburi, Compliance Officer of Aarthi Consultants Pvt Ltd.

Financial Impact

No financial impact is stated or quantified in the disclosure. The report is purely a procedural and compliance update confirming no activity for the reported period.